Professor Andrew Krentz
MB ChB, MD, FRCP, FFPM
Professor Andrew Krentz offers patient-centred expertise in diabetes and related cardiometabolic disorders.
Andrew has broad experience of diabetes and related disorders gained at leading institutions in the UK and USA. His main clinical interests are:
- Diabetes – type 2 diabetes; diabetes in older people; inpatient diabetes
- Endocrinology – thyroid; pituitary; male hypogonadism; female hyperandrogenism
- Cardiometabolic medicine – hypertension; dyslipidaemia; obesity; pre-diabetes
- Healthy longevity – frailty; cognitive impairment
He trained in diabetes and human metabolism at the University of Birmingham, UK (doctoral thesis: Metabolic Studies in Insulin Resistance) and the University of New Mexico School of Medicine, Albuquerque, USA. His professional expertise extends to preclinical and early-phase clinical drug development. In 2019, he was awarded honorary Fellowship of the Faculty of Pharmaceutical Medicine in recognition of his contributions to translational medicine including innovations in endocrinology practice and research. He has an active interest in precision diagnostics and therapeutics.
Senior academic and clinical appointments have included: Visiting Professor of Medical Sciences, Institute of Cardiovascular & Metabolic Research, University of Reading, UK (2018 to date); Professor of Endocrinology & Metabolism and Director of the Institute of Translational Medicine, Clore Life Sciences laboratory, University of Buckingham, UK (2016-17); Visiting Professor of Medicine, Institute of Diabetes for Older People, Bedfordshire & Hertfordshire Postgraduate Medical School, University of Bedfordshire, UK (2011-14); Senior Director for Scientific Services, ProSciento, USA (2011-16); Consultant Physician in Diabetes & Endocrinology, Southampton University Hospitals (1995-2009); Senior Clinical Lecturer, University of Southampton, UK (1997-2009); British Heart Foundation International Research Fellow, University of California San Diego, USA (2004-5);
His credentials in cardiometabolic medicine include:
- Accreditation in General (Internal) Medicine, Diabetes & Endocrinology
- Clinical Specialist accreditation by the European Society for Hypertension
- Member of the Medical, Scientific & Research Committee, Heart UK
- Fellow and elected Council Member of the Vascular, Lipid & Metabolic Medicine Section of the Royal Society of Medicine
- Clinical Lead for Diabetes, University Hospital Southampton (2005-7)
- Clinical Lead for Inpatient Diabetes Service, University Hospital Southampton (2007-9)
- Expert Advisor and Invited Reviewer for NICE Type 2 Diabetes guidelines
- Scientific Advisor to a novel algorithmic inpatient precision insulin dosing solution
Andrew has authored more than 200 scientific publications and a dozen well-received textbooks including Type 2 Diabetes in Practice (2001); Insulin Resistance: A Clinical Handbook (2002); The Metabolic Syndrome & Cardiovascular Disease (2007); Translational Research Methods for Diabetes, Obesity & Cardiometabolic Drug Development (2015).
He has an extensive record in undergraduate and postgraduate medical education including a visiting position as Clinical Instructor, University of California San Diego, USA (2015 to date).
Andrew is active on the editorial boards of several international medical journals; he is the founding Editor-in-Chief of Cardiovascular Endocrinology & Metabolism.